Abstract
The present invention provides a pharmaceutical composition for enhancing gastrointestinal tract absorption of a radioprotective drug comprising a therapeutically effective dosage amount of a bioactive polar radioprotective agent, such as ethiofos, its active metabolites, and pharmaceutically acceptable salts thereof and a chelating agent selected from the group consisting of EDTA, EGTA, citrate and therapeutically acceptable salts thereof. A method for enhancing the rate of gastrointestinal absorption of radioprotective agents is also provided.
Patent Number
5,167,947
Date Of Issue
Inventors
Richard S. Geary